← Open Payments lookup

CAMERON DENNIS: Open Payments

NPI 1922756196 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,905 in 94 payments from 34 companies in 2025. Trend: 2023 $1,775 · 2024 $2,174 · 2025 $1,905

Food & beverage: $1,905
CompanyPaymentsAmount
Merck Sharp & Dohme LLC11$234
Novartis Pharmaceuticals Corporation8$169
Daiichi Sankyo Inc.5$120
Incyte Corporation5$105
Astellas Pharma US Inc5$105
Janssen Biotech, Inc.5$92
Exelixis Inc.3$79
PFIZER INC.4$76
Gilead Sciences, Inc.3$75
Takeda Pharmaceuticals U.S.A., Inc.3$73

Products named: KEYTRUDA, ENHERTU, REBLOZYL, CABOMETYX, Vyloy, Trodelvy, KISQALI, RYBREVANT.

Industry payments across MS — which companies pay providers there.